| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/20/2007 | US7297476 Method of monitoring HIV assembly and maturation |
| 11/20/2007 | US7296690 Method and device for inactivating viruses |
| 11/20/2007 | CA2538966C Electrochemical cell |
| 11/20/2007 | CA2291440C Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 11/20/2007 | CA2221250C A sample presentation apparatus for mass spectrometry |
| 11/20/2007 | CA1341561C Manufacture and expression of large structural genes |
| 11/17/2007 | CA2587319A1 Cmklr regulation of adipogenesis and adipocyte metabolic function |
| 11/15/2007 | WO2007131202A2 Genomics of in-stent restenosis |
| 11/15/2007 | WO2007131135A2 Evaluating genetic disorders |
| 11/15/2007 | WO2007131108A2 Method to diagnose and increase fertility of mammalian semen using dnase as diagnostic marker and therapeutic agent |
| 11/15/2007 | WO2007131103A2 Direct printing of patterned hydrophobic wells |
| 11/15/2007 | WO2007130967A2 Novel oligonucleotide primers and methods for dna replication |
| 11/15/2007 | WO2007130951A2 Methods and apparatus for sequential amplification reactions |
| 11/15/2007 | WO2007130726A2 Methods for the detection of cancer |
| 11/15/2007 | WO2007130650A2 Methods for calculating codon pair-based translational kinetics values, and methods for generating polypeptide-encoding nucleotide sequences from such values |
| 11/15/2007 | WO2007130636A2 Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash) |
| 11/15/2007 | WO2007130627A2 Il-33 in the treatment and diagnosis of diseases and disorders |
| 11/15/2007 | WO2007130606A2 Analyzing translational kinetics using graphical displays of translational kinetics values of codon pairs |
| 11/15/2007 | WO2007130590A2 Men1 is a marker and therapeutic target for breast and prostate cancer |
| 11/15/2007 | WO2007130469A2 Induction of intracellular and secreted growth inhibitors and paracrine tumor-suppressive activity by rar ligands |
| 11/15/2007 | WO2007130461A2 Advanced selective plating media |
| 11/15/2007 | WO2007130431A2 FUNCTION OF ESTROGEN RELATED RECEPTOR GAMMA (ERRγ) IN INCREASING MITOCHONDRIAL BIOGENESIS |
| 11/15/2007 | WO2007130423A2 Biological markers of chronic wound tissue and methods of using for criteria in surgical debridement |
| 11/15/2007 | WO2007130403A2 REGULATION OF ApoB BY Hspl 10 PROTEINS AND RELATED COMPOSITIONS AND METHODS |
| 11/15/2007 | WO2007130399A2 Method of determining genetic predisposition for deficiency in health functions using snp analysis |
| 11/15/2007 | WO2007130050A1 Hybrid cells for treating early and late stage-ned melanoma |
| 11/15/2007 | WO2007129858A1 Novel use of mln51 gene and protein |
| 11/15/2007 | WO2007129778A1 Method for amplifying unknown dna sequence adjacent to known sequence |
| 11/15/2007 | WO2007129628A1 Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare by using the primer and probe |
| 11/15/2007 | WO2007129598A1 Method for screening of substance capable of increasing glutathione |
| 11/15/2007 | WO2007129428A1 Method for isolation of stem cell |
| 11/15/2007 | WO2007129219A2 Polymorphisms in growth hormone receptor, ghrelin, leptin, neuropeptide y, and uncoupling protein 2 genes and their associations with measures of performance and carcass merit in beef cattle |
| 11/15/2007 | WO2007129113A2 Phenotype prediction |
| 11/15/2007 | WO2007129000A2 Method for determining copy number |
| 11/15/2007 | WO2007128984A2 Breast cancer makers |
| 11/15/2007 | WO2007128980A1 A protease detection product |
| 11/15/2007 | WO2007128976A1 Lipovrotein senso |
| 11/15/2007 | WO2007128916A1 Detection of venous thromboembolic diseases by measurement of d-dimers and soluble fibrin levels |
| 11/15/2007 | WO2007128884A1 Novel genes and markers in type 2 diabetes and obesity |
| 11/15/2007 | WO2007128550A1 Biocompatible three dimensional matrix for the immobilization of biological substances |
| 11/15/2007 | WO2007128430A1 Molecular beacons for dna-photography |
| 11/15/2007 | WO2007128429A1 Biomarkers for endometrial proliferation |
| 11/15/2007 | WO2007128244A1 Method, oligonucleotide probe and test kit of predicting risk of negative pregnancy outcomes, and use thereof |
| 11/15/2007 | WO2007128121A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same |
| 11/15/2007 | WO2007128080A1 An assay for modulators of apoptosis |
| 11/15/2007 | WO2007107590A3 Fad-2 mutants and high oleic plants |
| 11/15/2007 | WO2007106603A9 Specific labeling of proteins with zinc finger tags and use of zinc-finger-tagged proteins for analysis |
| 11/15/2007 | WO2007106472A3 Non-mccj25-related lariat-peptide inhibitors of bacterial rna polymerase |
| 11/15/2007 | WO2007104763A9 Methods for the identification of lrrk2 interacting molecules and for the purification of lrrk2 |
| 11/15/2007 | WO2007104571A3 Method and test kit for diagnosing and/or making predictions about and/or estimating the effectiveness of therapeutic agents during the treatment of ovarian cancer, and method for planning an ovarian cancer treatment |
| 11/15/2007 | WO2007101664A3 Improved aspergillosis test in clinical samples |
| 11/15/2007 | WO2007100911A3 Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
| 11/15/2007 | WO2007100637A3 Methods for mutation detection |
| 11/15/2007 | WO2007099254A3 Method for identifying at least two groups of microorganisms |
| 11/15/2007 | WO2007095045A3 Electronic detection immunoassays that utilize a binder support medium |
| 11/15/2007 | WO2007089880A3 Method to detect breast cancer cells |
| 11/15/2007 | WO2007089145A3 Disease specific aso-probes for the detection of alpha- and beta-thalassemia mutations |
| 11/15/2007 | WO2007086935A3 Methods of amplifying and sequencing nucleic acids |
| 11/15/2007 | WO2007084485A3 Markers for assessing copd-related diseases |
| 11/15/2007 | WO2007084002A3 Antibiotics and methods for producing them. |
| 11/15/2007 | WO2007076143A3 Species-specific primer sets and identification of species-specific dna sequences using genome fragment enrichment |
| 11/15/2007 | WO2007071347A3 Selective marking of immunoglobulin glycans |
| 11/15/2007 | WO2007068725B1 Biochip self-calibration process |
| 11/15/2007 | WO2007060002A3 Method for the individualised prognosis, recommendation and/or monitoring of therapy and/or after-care of a tumorous disease |
| 11/15/2007 | WO2007058986A3 Methods for diagnosing and identifying effective therapeutics for major depressive disorder |
| 11/15/2007 | WO2007056680A3 Methods and arrays for identifying human microflora |
| 11/15/2007 | WO2007047912A3 Compositions and methods to detect legionella pneumophila nucleic acid |
| 11/15/2007 | WO2007047572A3 Methods for identifying multiple dna alteration markers in a large background of wild-type dna |
| 11/15/2007 | WO2007046095A3 Methods for testing the integrity of membranes and optically or electrochemically detectable nanoprobes thereof |
| 11/15/2007 | WO2007044057A3 Methods for quantifying microrna precursors |
| 11/15/2007 | WO2007038501A3 Rheumatoid arthritis markers |
| 11/15/2007 | WO2007035881A3 Apparatus and method for solid-phase kinetic analysis of templated elongation reactions |
| 11/15/2007 | WO2007035651A3 Systemic lupus erythematosus diagnostic assay |
| 11/15/2007 | WO2007020632A3 Methods and compositions for determining a level of biologically active serum paraoxonase |
| 11/15/2007 | WO2007011392A3 Crystal structure of domain 111 of west nile virus envelope protein-fab fragment of neutralizing antibody complex |
| 11/15/2007 | WO2007011367A3 Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16s ribosomal rna gene and identification of bacterial species by amplicon sequencing |
| 11/15/2007 | WO2007001324A3 Methods and materials for determining pain sensitivity and predicting and treating related disorders |
| 11/15/2007 | WO2006108135A8 Laser microdissection and microarray analysis of breast tumors reveal estrogen receptor related genes and pathways |
| 11/15/2007 | WO2006086547A3 Automated biological indicator incubator |
| 11/15/2007 | WO2006081580A3 System for and method of patch clamp analysis |
| 11/15/2007 | WO2006078256A3 Polypeptides having xylanase activity and polynucleotides encoding same |
| 11/15/2007 | WO2006076497A3 Osplation of pathogenic prions |
| 11/15/2007 | WO2006075245A3 Systems, methods, and compositions for detection of human papilloma virus in biological samples |
| 11/15/2007 | WO2006060171A3 Methods and compositions related to phage-nanoparticle assemblies |
| 11/15/2007 | WO2006029014A3 rRNA OLIGONUCLEOTIDE PROBES FOR SPECIFIC DETECTION OF MYCOBACTERIA AND METHODS OF USE THEREOF |
| 11/15/2007 | WO2006026602A3 Alternatively spliced pre-mrna transcripts in neurodegenerative disease |
| 11/15/2007 | WO2006020899A3 Markers for autoimmune disease detection |
| 11/15/2007 | WO2006018643A3 Electrochemical sensors |
| 11/15/2007 | WO2005118878A3 Methods of screening for cell proliferation or neoplastic disorders |
| 11/15/2007 | WO2005116261A3 Rna expression microarrays |
| 11/15/2007 | WO2005100601A3 L-sign polymorphisms and methods involving use of same |
| 11/15/2007 | WO2005059509A3 Biosensors for detecting macromolecules and other analytes |
| 11/15/2007 | WO2005046572A3 Targeted delivery of controlled release polymer systems |
| 11/15/2007 | WO2005044986A3 Methods and compositions for detection of segmented negative strand rna viruses |
| 11/15/2007 | WO2005031303A3 Soluble phospholipids for use in clotting factor assays |
| 11/15/2007 | WO2005023186A3 Methods of identifying agents that inhibit the growth of cancer cells |
| 11/15/2007 | WO2005017105A3 Regio- and enantioselective alkane hydroxylation with modified cytochrome p450 |
| 11/15/2007 | WO2004085667A3 Methods and compositions for detecting the presence of target nucleic acids in a sample |
| 11/15/2007 | WO2004058988A3 Binding agents which inhibit myostatin |
| 11/15/2007 | WO2004048538A3 Csnks as modifiers of the rac pathway and methods of use |